^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    L-pampo

    Associations
    News
    Trials
    Company:
    CHA Vaccine Institute
    Drug class:
    TLR3 agonist, TLR1 agonist, TLR2 agonist
    Related drugs:
    Associations
    News
    Trials